Pittsburgh lab receives pathology certification


Castle (Nasdaq: CSTL), a diagnostic company, entered the Pittsburgh market in December 2021 with the acquisition of biotech firm Cernostics.

Previous Economist provides insight into potential recession, growth opportunities in Arizona
Next Landscape Workshop continues Southeastern growth with Georgia acquisition

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *